Literature DB >> 8795472

Hyperhomocysteinaemia and premature coronary artery disease in the Chinese.

Y I Lolin1, J E Sanderson, S K Cheng, C F Chan, C P Pang, K S Woo, J R Masarei.   

Abstract

OBJECTIVES: To examine the prevalence of hyperhomocysteinaemia and compare it with the classic risk factors and vitamin status in Hong Kong Chinese patients with premature atherosclerotic coronary artery disease.
DESIGN: Case-control study.
SETTING: General hospital and community.
SUBJECTS: Forty five patients (39 males) with significant coronary artery disease confirmed by angiography (32 post myocardial infarction) and 23 healthy volunteers (17 male), all aged less than 55 years. INTERVENTION: Standardised methionine-loading test. MAIN OUTCOME MEASURES: Coronary artery disease, risk factors.
RESULTS: More patients than controls had fasting hyperhomocysteinaemia (10/45 v 2/23, P = 0.122), post-methionine hyperhomocysteinaemia (17/45 v 1/23, P = 0.008), and an abnormal response to methionine (15/45 v 1/23, P = 0.015). A history of smoking was more frequent in patients (3/23 v 25/45, P = 0.002). Sixteen of 17 patients with hyperhomocysteinaemia but only nine of 28 with normohomocysteinaemia were smokers (P = 0.0002). Fasting plasma cholesterol concentrations (mean (SD)) were higher in hyperhomocysteinaemic patients (6.41 (1.58) mmol/l) than in controls (5.53 (0.90) mmol/l) (P = 0.042). Serum vitamin B-12 was not reduced and serum folate was higher in hyperhomocysteinaemic patients (35 (4) nmol/l) than normohomocysteinaemic patients (26 (9) nmol/l) (P = 0.009).
CONCLUSIONS: Although the prevalence of hyperhomocysteinaemia in Hong Kong Chinese is similar to that in white subjects, hyperhomocysteinaemia is not an independent risk factor for coronary artery disease and is associated with smoking. This may be of some consequence in view of the change to a more Western diet with more animal protein, and therefore methionine, coupled with a high frequency of cigarette smokers in this region. The causes of the hyperhomocysteinaemia are multifactorial but in this pilot study a deficiency of folate and/or vitamin B-12 did not seem to be one of them.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8795472      PMCID: PMC484457          DOI: 10.1136/hrt.76.2.117

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  38 in total

Review 1.  Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis.

Authors:  M R Malinow
Journal:  Circulation       Date:  1990-06       Impact factor: 29.690

2.  The pathogenesis of coronary artery disease. A possible role for methionine metabolism.

Authors:  D E Wilcken; B Wilcken
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

3.  Hyperhomocysteinemia: an independent risk factor for vascular disease.

Authors:  R Clarke; L Daly; K Robinson; E Naughten; S Cahalane; B Fowler; I Graham
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

4.  Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects.

Authors:  A Araki; Y Sako; Y Fukushima; M Matsumoto; T Asada; T Kita
Journal:  Atherosclerosis       Date:  1989-10       Impact factor: 5.162

5.  Treatment of mild hyperhomocysteinemia in vascular disease patients.

Authors:  D G Franken; G H Boers; H J Blom; F J Trijbels; P W Kloppenborg
Journal:  Arterioscler Thromb       Date:  1994-03

Review 6.  Plasma homocysteine and methionine tolerance in early-onset vascular disease.

Authors:  L Brattström; B Israelsson; B Hultberg
Journal:  Haemostasis       Date:  1989

Review 7.  Mechanisms of thrombogenesis and accelerated atherogenesis in homocysteinaemia.

Authors:  D E Wilcken; N P Dudman
Journal:  Haemostasis       Date:  1989

Review 8.  Inborn errors of metabolism causing homocysteinemia and related vascular involvement.

Authors:  F Skovby
Journal:  Haemostasis       Date:  1989

Review 9.  Clinical and laboratory features of homocystinuria.

Authors:  E Cacciari; S Salardi
Journal:  Haemostasis       Date:  1989

10.  Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease.

Authors:  S S Kang; P W Wong; A Susmano; J Sora; M Norusis; N Ruggie
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

View more
  9 in total

1.  Homocysteine: the new player in the field of coronary risk.

Authors:  G Montalescot
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

2.  Hyperhomocysteinaemia.

Authors:  T O Cheng
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

3.  Hyperhomocysteinaemia and premature coronary artery disease in the Chinese.

Authors:  M A Mansoor
Journal:  Heart       Date:  1997-04       Impact factor: 5.994

4.  Homocysteinaemia and coronary atherosclerosis.

Authors:  T O Cheng
Journal:  Heart       Date:  1997-04       Impact factor: 5.994

Review 5.  [Laboratory diagnosis in preventive cardiology].

Authors:  M Soufi; B Noll; M Herzum; B Simon; A Steinmetz; B Maisch; J R Schaefer
Journal:  Herz       Date:  1999-02       Impact factor: 1.443

6.  Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.

Authors:  G L Booth; E E Wang
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

7.  Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease.

Authors:  J J Sung; J E Sanderson
Journal:  Heart       Date:  1996-10       Impact factor: 5.994

8.  Homocysteine, vitamin B12 and folate levels in premature coronary artery disease.

Authors:  Saeed Sadeghian; Faramarz Fallahi; Mojtaba Salarifar; Gholamreza Davoodi; Mehran Mahmoodian; Nader Fallah; Soodabeh Darvish; Abbasali Karimi
Journal:  BMC Cardiovasc Disord       Date:  2006-09-26       Impact factor: 2.298

9.  Cigarette smoking reduced renal function deterioration in hypertensive patients may be mediated by elevated homocysteine.

Authors:  Feifei Huang; Jie Chen; Xun Liu; Feng Han; Qingqing Cai; Guicheng Peng; Kun Zhang; Weiqing Chen; Jingfeng Wang; Hui Huang
Journal:  Oncotarget       Date:  2016-12-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.